Literature DB >> 17229699

Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions.

Cecilia Tami1, Erica Silberstein, Mohanraj Manangeeswaran, Gordon J Freeman, Sarah E Umetsu, Rosemarie H DeKruyff, Dale T Umetsu, Gerardo G Kaplan.   

Abstract

The hepatitis A virus cellular receptor 1 (HAVCR1/TIM1), a member of the T-cell immunoglobulin mucin (TIM) family, is an important atopy susceptibility gene in humans. The exact natural function of HAVCR1/TIM1 and the inverse association between HAV infection and prevention of atopy are not well understood. To identify natural ligands of human HAVCR1/TIM1, we used an expression cloning strategy based on the binding of dog cells transfected with a human lymph node cDNA library to a HAVCR1/TIM1 Fc fusion protein. The transfected cells that bound to the human HAVCR1/TIM1 Fc contained cDNA of human immunoglobulin alpha 1 heavy (Igalpha1) and lambda light (Iglambda) chain and secreted human IgA1lambda antibody that bound to the cell surface. Cotransfection of the isolated Igalpha1 and Iglambda cDNAs to naïve dog cells resulted in the secretion of IgA1lambda that bound to HAVCR1/TIM1 Fc but not to a poliovirus receptor Fc fusion protein in a capture enzyme-linked immunosorbent assay. The interaction of HAVCR1/TIM1 with IgA was inhibited by monoclonal antibodies (MAbs) against Igalpha1 and Iglambda, excess IgA1lambda, or anti-HAVCR1/TIM1 MAb. IgA did not inhibit HAV infection of African green monkey cells, suggesting that the IgA and the virus binding sites are in different epitopes on HAVCR1/TIM1. IgA enhanced significantly the neutralization of HAV by HAVCR1/TIM1 Fc. Our results indicate that IgA1lambda is a specific ligand of HAVCR1/TIM1 and that their association has a synergistic effect in virus-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229699      PMCID: PMC1866050          DOI: 10.1128/JVI.01585-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1.

Authors:  E Silberstein; G Dveksler; G G Kaplan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  IgA and the IgA Fc receptor.

Authors:  M van Egmond; C A Damen; A B van Spriel; G Vidarsson; E van Garderen; J G van de Winkel
Journal:  Trends Immunol       Date:  2001-04       Impact factor: 16.687

3.  The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4.

Authors:  P Thompson; J Lu; G G Kaplan
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.

Authors:  Chen Zhu; Ana C Anderson; Anna Schubart; Huabao Xiong; Jaime Imitola; Samia J Khoury; Xin Xiao Zheng; Terry B Strom; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2005-11-13       Impact factor: 25.606

5.  Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.

Authors:  G Kaplan; A Totsuka; P Thompson; T Akatsuka; Y Moritsugu; S M Feinstone
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

6.  Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor.

Authors:  A Dotzauer; U Gebhardt; K Bieback; U Göttke; A Kracke; J Mages; S M Lemon; A Vallbracht
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.

Authors:  H M Wolf; I Hauber; H Gulle; A Samstag; M B Fischer; R U Ahmad; M M Eibl
Journal:  Clin Exp Immunol       Date:  1996-09       Impact factor: 4.330

Review 8.  Host immune response to hepatitis A virus.

Authors:  J T Stapleton
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

9.  Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus).

Authors:  L V Asher; L N Binn; T L Mensing; R H Marchwicki; R A Vassell; G D Young
Journal:  J Med Virol       Date:  1995-11       Impact factor: 2.327

10.  Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes.

Authors:  H M Wolf; M B Fischer; H Pühringer; A Samstag; E Vogel; M M Eibl
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

View more
  15 in total

1.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: microbes, apoptosis and TIM-1 in the development of asthma.

Authors:  D T Umetsu; R H Dekruyff
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

2.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 3.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Authors:  Gordon J Freeman; Jose M Casasnovas; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

4.  Vectorial entry and release of hepatitis A virus in polarized human hepatocytes.

Authors:  Michelle J Snooks; Purnima Bhat; Jason Mackenzie; Natalie A Counihan; Nicola Vaughan; David A Anderson
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.

Authors:  Alla Kachko; Maria Isabel Costafreda; Iryna Zubkova; Jerome Jacques; Kazuyo Takeda; Frances Wells; Gerardo Kaplan; Marian E Major
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity.

Authors:  Hyun-Hee Lee; Everett H Meyer; Sho Goya; Muriel Pichavant; Hye Young Kim; Xia Bu; Sarah E Umetsu; Jennifer C Jones; Paul B Savage; Yoichiro Iwakura; Jose M Casasnovas; Gerardo Kaplan; Gordon J Freeman; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

7.  TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver transplantation.

Authors:  Yu Zhang; Yuanxing Liu; Hui Chen; Xiaoxiao Zheng; Shangzhi Xie; Wei Chen; Haofeng Ji; Shusen Zheng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 8.  The costimulatory role of TIM molecules.

Authors:  Roselynn Rodriguez-Manzanet; Rosemarie DeKruyff; Vijay K Kuchroo; Dale T Umetsu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

9.  TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

Authors:  Norimoto Kobayashi; Piia Karisola; Victor Peña-Cruz; David M Dorfman; Masahisa Jinushi; Sarah E Umetsu; Manish J Butte; Haruo Nagumo; Irene Chernova; Baogong Zhu; Arlene H Sharpe; Susumu Ito; Glenn Dranoff; Gerardo G Kaplan; Jose M Casasnovas; Dale T Umetsu; Rosemarie H Dekruyff; Gordon J Freeman
Journal:  Immunity       Date:  2007-12       Impact factor: 31.745

10.  Costimulatory pathways in transplantation.

Authors:  Nina Pilat; Mohamed H Sayegh; Thomas Wekerle
Journal:  Semin Immunol       Date:  2011-05-26       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.